To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5730

Full metadata record

DC Field	Value	Language
dc.contributor.author	Zaynutdinova D.L., Qudratova M.F., Qo’ziyeva M.G., Muhammadaminova D.R., Axtamov A.J.	-
dc.date.accessioned	2023-01-10T07:36:41Z	-
dc.date.available	2023-01-10T07:36:41Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/5730	-
dc.description.abstract	The term “thalassemia” refers to a group of autosomal-recessive blood diseases charaeterized by a decrease in the synthesis of one of two types of polypeptide chains of globin (α or β), that form a molecule of adult hemoglobin(HbA, α2β2). This leads to a decrease in the filling of erythrocytes with hemoglobin and anemia. In Uzbekistan, the birth rate with this disease is 10-15 per year. At present in the Republic of Uzbekistan, 184 patients with thalassemia are registered at the Research Institute of Hematology and Blood Transfuzion at the Dispensary	en_US
dc.language.iso	en_US	en_US
dc.publisher	USA	en_US
dc.relation.ispartofseries	УДК;	-
dc.subject	anemia, hemoglobinopathy, thalassemia, hemosiderosis	en_US
dc.title	To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Zaynutdinova D.L. O'zbek.pdf	To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia	449.15 kB	Adobe PDF	View/Open

DSpace JSPUI